Sarsia Overview

Sarsia is an early-stage venture capital firm based in Bergen, Norway, focusing on investments in life sciences and technology sectors, particularly in energy, sustainability, and biotechnology. Established in 2006, Sarsia has launched multiple funds, including Sarsia Seed Fund I in 2007, Sarsia Seed Fund II in 2017, and Sarsia Fund III in 2023, collectively managing over 1.3 billion NOK. The firm has screened nearly 2,000 companies and currently holds a portfolio of 29 companies. Notable investments include Calluna Pharma, Cetasol, and Qbee. Sarsia emphasizes supporting technologies that improve quality of life and reduce environmental impact, aiming to accelerate the green transition and build sustainable companies for the future.

Is Sarsia the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Sarsia, along with a list of other relevant VCs, is available on Hopohopo.io.